Apollo Hospitals' net profit grew by 32% to 630 crore rupees, revenue increased by 23%

Apollo Hospitals Enterprises (AHEL), a leading hospital chain, reported a 32% growth in consolidated net profit during the second quarter of the fiscal year 2026-27 (Q2FY27). Profit reached 630 crore rupees, compared to 477 crore rupees in the same period last fiscal year. The company's consolidated revenue increased by 23%, amounting to 7,615 crore rupees versus 6,189 crore rupees in Q2FY26.

Consolidated Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) grew by 29% to 1,191 crore rupees, while this figure was 924 crore rupees in Q2 of the last fiscal year. Krishnanan Ahileswaran, CFO of AHEL, noted that all three segments showed good results. He highlighted growth in hospitals, especially in specializations such as cardiology, oncology, gastroenterology, and orthopedics.

Furthermore, international patients increased by 37% due to the recovery of flow from Bangladesh, as well as a good influx of patients from Africa and Europe. Apollo's medical services revenue in Q2FY27 was 3,900 crore rupees, which is 23% more than the previous year. EBITDA in this segment reached 937 crore rupees, which is 20% higher than in Q2FY26, and net profit was 486 crore rupees compared to 408 crore rupees in Q2FY26, demonstrating a 19% growth.

Pratap S. Reddy, founder and chairman of the board of directors of Apollo Hospitals Group, stated that the quarterly results were supported by revenue driven by a significant increase in volume in specialized centers. He expressed satisfaction with the business progress and the contribution of each hospital to the Group.

The dividend per share from continuing operations in Q2FY27 was 43.71 rupees. Overall occupancy in Q2FY27 reached 73%, and occupancy in established units was 76%. Medical EBITDA reached 937 crore rupees, which is 20% higher. The company plans to expand its infrastructure, having 5,800 beds in total capacity and 4,700 beds over the next five years, with capital expenditure financing of 7,100 crore rupees to be done through internal accruals.

The AHLL segment, dealing with diagnostics and retail, demonstrated a 20% year-on-year revenue growth in Q2FY27. Diagnostic business revenue grew by 24% year-on-year. Within the HealthCo segment, another 222 stores were added, bringing the total number to 222. Gross Merchandise Value (GMV) grew by 27% to 571 crore rupees in Q2FY27, exceeding 450 crore rupees in Q2FY26.

Reddy also reported on the construction progress of hospitals in Hyderabad Financial District, Sonarpur in Kolkata, and Sarjapur in Bengaluru, which were commissioned in Q1 FY27. Additionally, the facility in Gurugram remains on schedule for commissioning in Q3 FY27.

Similar stories

business-standard.comNovember 4, 17:13

Dr Lal PathLabs' profit grew by 27.5% in the second quarter to 194 crore rupees due to volume growth

Dr Lal PathLabs, a major diagnostic operator based in Delhi, reported a 27.5% year-on-year growth in consolidated net profit for the September quarter (Q2) of the fiscal year 2026-27 (FY27). This growth was achieved through an increase in testing revenues.

The company's net profit in Q2 FY27 amounted to 194 crore rupees, which is higher than the 152 crore rupees recorded during the same period last year. The main driver of this growth was the increase in sample volumes, which rose by 13.6% year-on-year to reach 28.8 million.

Furthermore, patient coverage in the network increased by 9% year-on-year, reaching 9 million in September, compared to 8.2 million in the same period the previous year. Consequently, the network's revenue increased by 19.6% year-on-year, reaching 874 crore rupees compared to 731 crore rupees in Q2 FY26.

Shankha Banerjee, CEO of DLPL, noted that there is a growing demand for high-complexity testing and specialized analyses, supported by increased awareness among doctors and patients. Operationally, the EBITDA margin increased by 25%, reaching 280 crore rupees from 224 crore rupees, and the EBITDA margin improved to 32.1% from 30.7%.

He also added that the company's future focus will be on expanding access to advanced diagnostics by strengthening capabilities in areas such as genomics, oncology, reproductive health, transplant diagnostics, and rare diseases.

As of September 30, 2026, DLPL, the largest provider of diagnostic services in India, operates 312 clinical laboratories, including the national reference laboratory in Delhi and regional reference laboratories in Kolkata, Bengaluru, and Mumbai. The network also includes 7,727 Patient Service Centers (PSC) and 13,935 Pickup Points (PUP), serving private patients, hospitals, healthcare professionals, and corporate clients.

DLPL's board of directors also approved an additional investment of up to 49.5 crore rupees in its wholly-owned subsidiary in Dubai, Dr Lal PathLabs FZCO, to meet its business and operational needs. In regulatory filings, DLPL indicated that this subsidiary will make further investments in its subsidiary Sunshine Healthcare Limited (SHL) in Ghana.

The results were announced during market trading. DLPL shares closed on the BSE on Wednesday 5.1% higher, at a price of 2,028.95 rupees per share.

business-standard.comOctober 29, 19:08

Brigade Group's profit rose by 29% in the second quarter to 219 crore rupees, while revenue decreased by 12.6%

Brigade Enterprises Ltd, based in Bangalore, reported a rise in net profit of 28.8% to 219 crore rupees in the second quarter of fiscal year 27 (Q2FY27) compared to the same period last year. This growth is attributed to stable demand that aligns with the launch of new projects.

However, the company's revenue, which focuses on South India, declined by 12.6% year-on-year (Y-o-Y), reaching 1,250 crore rupees compared to 1,430 crore rupees in the corresponding quarter of the previous year. This was reported in the stock exchange filing published on Thursday with results for the September quarter.

Earnings Before Interest, Taxes, Depreciation, and Amortization (Ebitda) increased by 27.5% in Q2FY27, reaching 478 crore rupees, compared to 375 crore rupees in the corresponding quarter of the previous fiscal year.

Listen to this article

Pavitra Shankar, Managing Director of Brigade Enterprises Ltd, noted that residential segments continue to drive growth, supported by sustained demand and a strong project portfolio. She emphasized that customers are increasingly prioritizing quality, location, larger homes, and improved amenities, and the company continues to observe steady demand in both mid-range and premium segments. Furthermore, the festive season boosted customer engagement in the residential and retail businesses.

The group stated that project launch rates are gaining momentum, with property sales for the quarter reaching 1,827 crore rupees across a volume of 1.3 million square feet (msf). Shankar added that the company is prepared to sustain this momentum and ensure stable long-term growth. Brigade Enterprises shares fell by 1.39% and closed at 531 rupees on the BSE on Thursday.

During the quarter, the company launched projects totaling 2.4 msf with a Gross Development Value (GDV) of approximately 3,000 crore rupees. Brigade's portfolio generated revenue of 760 crore rupees, with an Ebitda of 175 crore rupees, which is 59% higher than in Q2FY26, at a margin of 23%.

Revenue from the rental business amounted to 329 crore rupees, with an Ebitda of 242 crore rupees, which is 9% higher than in Q2FY26, with a margin of 74%. As of September 2026, occupancy reached 90%. In the hospitality segment, which includes hotels the company builds for brand management, revenue in Q2FY27 was 161 crore rupees, and Ebitda was 59 crore rupees, which is 41% higher than in Q2FY26, with a margin of 37%.

business-standard.comOctober 26, 16:13

IOB's profit grew by 56% to 1963 crore rupees in the second quarter due to improved asset quality

Indian Overseas Bank (IOB), based in Chennai, reported a 56% increase in net profit during the second quarter of the fiscal year 27, reaching 1963 crore rupees. This growth compared to 1259 crore rupees in the quarter from July to September of fiscal year 26, and is attributed to increased interest income and improved asset quality.

The bank's total income for the reporting period increased by 13%, amounting to 10,428 crore rupees. IOB's interest income in Q2 FY27 rose by 17% to 9,201 crore rupees, compared to 7,851 crore rupees in the same period last year.

Ajay Kumar Srivastava, Managing Director and CEO of IOB, noted that net interest income grew by 26% during the quarter. He also highlighted the good asset quality and low write-off levels in the system.

Net Interest Income (NII) for the quarter increased by 26.4% to 3,867 crore rupees, compared to 3,059.3 crore rupees a year earlier. Srivastava added that write-offs remained under control at 240 crore rupees, and the provisioning ratio was only 0.07%, which is one of the lowest in the banking system, and the bank consistently maintains this figure.

The Non-Performing Asset (NPA) ratio decreased by 64 basis points (bps) year-on-year (Y-o-Y) to 1.19%, while the Net NPA ratio fell by 12 bps year-on-year to 0.16%. Credit costs also decreased by 1 bp year-on-year to 0.17%. During the quarter, 647 crore rupees were recovered against NPAs, which is 2.95 times higher than quarterly write-offs. The Capital to Risk-Weighted Assets Ratio (CRAR) increased by 66 bps year-on-year to 18.60%. Return on Assets (RoA) improved to 1.53% from 1.20% last year, which is 33 bps higher. Return on Equity (RoE) grew to 24.58% from 19.95% last year, an increase of 463 bps.

The bank's total deposits increased by 20.16% to 4.07 trillion rupees from 3.39 trillion rupees. Current Account Savings Account (CASA) deposits also grew by 20.73% year-on-year to 1.65 trillion rupees, and the internal CASA ratio improved by 13 bps year-on-year to 41.14%. The volume of loans disbursed in Q2 FY27 reached 3.45 trillion rupees, showing a growth of 24.35% compared to 2.77 trillion rupees last year.

Srivastava stated that, according to preliminary estimates, IOB will require additional provisioning of about 2,600–2,800 crore rupees under Expected Credit Losses (ECL). He clarified that the bank has already created ECL provisions of about 2,700 crore rupees, meaning that 100% of the required amount is already secured in the balance sheet as projected ECL reserves.

Furthermore, he mentioned the successful performance of the gold loan portfolio and the development of several programs to meet the needs of various segments of society with competitive interest rates. Srivastava added that the jewelry loan portfolio is very sound, with outstanding loans amounting to nearly 1.36 trillion rupees, and shows no signs of stress. The bank maintains a Loan-to-Value (LTV) ratio of about 60–62%, which adequately accounts for price fluctuations.